WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.

Raccontata dacnbc.comapnews.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo3 mesi fa

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.

originale
apnews.com3 mesi fa

As demand for GLP-1 pills and shots surges, healthy habits are still key

Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 18 marzo 2026·cnbc.com

    Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

    Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.

  2. sabato 21 marzo 2026·cnbc.com

    GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

    For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.

  • lunedì 23 marzo 2026·apnews.com

    As demand for GLP-1 pills and shots surges, healthy habits are still key

    Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.